Rita M. O'Connor - 15 Mar 2022 Form 4 Insider Report for PLx Pharma Inc.

Role
Chief Financial Officer
Signature
/s/ Rita M. O'Connor
Issuer symbol
N/A
Transactions as of
15 Mar 2022
Net transactions value
+$50,122
Form type
4
Filing time
16 Mar 2022, 08:33:47 UTC
Previous filing
24 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLXPQ Common Stock Purchase $36,600 +10,000 +77% $3.66 22,970 15 Mar 2022 Direct
transaction PLXPQ Common Stock Purchase $13,522 +3,700 +16% $3.65 26,670 15 Mar 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.